TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes (Q37566878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

acute myeloid leukemia

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Armin Ghobadi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Timothy A Graubert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Amanda F Cashen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Camille N Abboud

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Keith Stockerl-Goldstein

object named as

Keith E Stockerl-Goldstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

John S Welch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Allegra A Petti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Christopher A Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Catrina C Fronick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michelle O'Laughlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Robert S Fulton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Richard K Wilson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Jack D Baty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Eric J Duncavage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Bevan Tandon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Yi-Shan Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Lukas D Wartman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Geoffrey L Uy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michael H Tomasson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Iskra Pusic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Rizwan Romee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Todd A Fehniger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Ravi Vij

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Stephen T Oh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Mark A Schroeder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Meagan A Jacoby

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sharon E Heath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Kierstin Luber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Megan R Janke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Niloufer Khan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Madina J Sukhanova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Wendy Stock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Matthew J Walter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Peter Westervelt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Daniel C Link

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

John F DiPersio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Timothy J Ley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

language of work or name

English

0 references

publication date

1 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

2023-2036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

29 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Decitabine in the treatment of acute myeloid leukemia in elderly patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Genomic impact of transient low-dose decitabine treatment on primary AML cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Detectable clonal mosaicism from birth to old age and its relationship to cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: retrospective analysis of survival after long-term follow-up

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Gro

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5217532

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27959731

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27959731

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1605949

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

PubMed publication ID

27959731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27959731%20AND%20SRC:MED&resulttype=core&format=json